HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefania Kinspergher Selected Research

Hemoglobins (Hemoglobin)

1/2023Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefania Kinspergher Research Topics

Disease

14Prostatic Neoplasms (Prostate Cancer)
01/2021 - 04/2016
7Neoplasms (Cancer)
11/2020 - 05/2014
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2015
4Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2023
4Lung Neoplasms (Lung Cancer)
01/2022 - 01/2020
3Adenocarcinoma of Lung
03/2020 - 05/2014
2COVID-19
11/2021 - 11/2020
1Back Pain (Backache)
01/2022
1Arthralgia (Joint Pain)
01/2022
1Myalgia
01/2022
1Brain Neoplasms (Brain Tumor)
02/2021
1Disease Progression
01/2021
1Immune System Diseases (Immune Disorders)
06/2020
1Autoimmune Diseases (Autoimmune Disease)
06/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Myasthenia Gravis
01/2020
1Myositis (Idiopathic Inflammatory Myopathies)
01/2020
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
01/2020
1Diplopia (Double Vision)
01/2020
1Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2014

Drug/Important Bio-Agent (IBA)

6AndrogensIBA
11/2021 - 02/2018
5Immune Checkpoint InhibitorsIBA
01/2023 - 01/2015
5enzalutamideIBA
01/2021 - 01/2018
4Tyrosine Kinase InhibitorsIBA
01/2023 - 05/2014
3Biomarkers (Surrogate Marker)IBA
01/2023 - 04/2016
3Docetaxel (Taxotere)FDA Link
01/2021 - 02/2018
3Androgen Receptors (Androgen Receptor)IBA
06/2020 - 04/2016
2cabozantinibIBA
01/2023 - 01/2023
2pazopanibFDA Link
01/2023 - 01/2023
2Hormones (Hormone)IBA
06/2020 - 09/2019
2abirateroneIBA
06/2020 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
03/2020 - 05/2014
2PlatinumIBA
01/2020 - 01/2018
2Abiraterone AcetateIBA
03/2019 - 02/2018
1Proton Pump InhibitorsIBA
01/2023
1Hemoglobins (Hemoglobin)IBA
01/2023
1LigandsIBA
01/2022
1pembrolizumabIBA
01/2021
1Prednisone (Sone)FDA LinkGeneric
01/2021
1Phosphotransferases (Kinase)IBA
03/2020
1Tyrosine (L-Tyrosine)FDA Link
03/2020
1Circulating Tumor DNAIBA
03/2020
1AntibodiesIBA
01/2020
1NivolumabIBA
01/2020
1RadiumIBA
03/2019
1sipuleucel-T (APC8015)FDA Link
03/2019
1cabazitaxelFDA Link
03/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018
1Gefitinib (Iressa)FDA Link
05/2015
1VaccinesIBA
01/2015
1B7-H1 AntigenIBA
01/2015
1Angiogenesis InhibitorsIBA
01/2015
1Anaplastic Lymphoma KinaseIBA
05/2014
1Thyroid Nuclear Factor 1IBA
05/2014

Therapy/Procedure

13Castration
01/2021 - 04/2016
10Therapeutics
01/2023 - 01/2015
4Immunotherapy
01/2023 - 01/2015
4Drug Therapy (Chemotherapy)
01/2022 - 01/2018